VEDOLIZUMAB SUBCUTANEOUSLY: REAL-WORLD DATA BEFORE AND AFTER SWITCH IN IBD PATIENTS - A HESSIAN COHORT
Alica Kubesch 1
Nina Kruse 1
Üminye Balaban 2
Katharina Stratmann 2
Kathrin Sprinzl 2
Antje Dienethal 2
Mate Knabe 2
Thomas Krause 3
Stefan Zeuzem 3
Irina Blumenstein 3
1 University-Hospital Frankfurt, Frankfurt am Main, Germany
2 University Hospital, Goethe University, Frankfurt am Main, Germany
3 Gastroenterologie Opernstraße, Kassel, Germany
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]